Cargando…
Treatment of the later stages of Parkinson’s disease – pharmacological approaches now and in the future
The problems associated with the pharmacological treatment of the later stages of Parkinson’s disease (PD) remain those seen over many years. These centre on a loss of drug effect (‘wearing off’) with disease progression, the occurrence of dyskinesia, notably with L-dopa use and the appearance of no...
Autor principal: | Jenner, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429454/ https://www.ncbi.nlm.nih.gov/pubmed/25973178 http://dx.doi.org/10.1186/2047-9158-4-3 |
Ejemplares similares
-
Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
por: Tan, Yu-Yan, et al.
Publicado: (2022) -
Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016) -
The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022) -
Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives
por: Pennisi, Grazia, et al.
Publicado: (2019) -
Precision treatment in colorectal cancer: Now and the future
por: Yau, Tung On
Publicado: (2019)